$8.32
Value $813M
MGTX and UNH stock compared: price, dividend, valuation and results, from SEC filings.
$8.32
Value $813M
$349.91
Value $318B
MeiraGTx (MGTX) has a market value of $813M and UnitedHealth (UNH) $318B. Over the last year, with dividends, MGTX moved +5.6% and UNH +12.1%. The P/E is 10.4 for MGTX and 20.0 for UNH. Dividend yield: MGTX none, UNH 2.59%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
MGTX$813M
UNH$318B
UNH is 391 times MGTX
Revenue, 12 months
MGTX$402M
UNH$450B
UNH is 1,119 times MGTX
Net income, 12 months
MGTX$78M
UNH$15.9B
UNH is 203 times MGTX
Operating margin
MGTX44.8%
UNH5.3%
39.5 points apart
ROIC
MGTX84.3%
UNH11.3%
73.0 points apart
P/E
MGTX10.4
UNH20.0
UNH is 1.9 times MGTX
Dividend yield
MGTX0.0%
UNH2.6%
2.6 points apart
5-year return
MGTX-58.1%
UNH-14.7%
43.4 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
MGTX-58.1%
UNH-14.7%
| Period | MGTXWith dividends | UNHWith dividends |
|---|---|---|
| 1 year since November 17, 2025 | +5.6%Price +5.6% | +12.1%Price +9.2% |
| 3 years since November 17, 2023 | +47.5%+13.8% a yearPrice +47.5% | -30.5%-11.4% a yearPrice -34.8% |
| 5 years since November 17, 2021 | -58.1%-16.0% a yearPrice -58.1% | -14.7%-3.1% a yearPrice -22.1% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
MGTXMeiraGTxUNHUnitedHealth
| Price | $8.32 | $349.91 |
|---|---|---|
| Market value | $813M | $318B |
| Enterprise value (EV) | – | $363B |
| P/E | 10.4 | 20.0 |
| P/E, 5-year median | – | 25.0 |
| P/B | 3.8 | 3.1 |
| EV/EBIT | – | 15.2 |
| Free cash flow yield | – | 7.2% |
| Revenue, 12 months | $402M | $450B |
|---|---|---|
| Net income, 12 months | $78M | $15.9B |
| Free cash flow, 12 months | -$3.0M | $22.8B |
| Earnings per share, 12 months | $0.80 | $17.52 |
| Revenue growth, year on year | 144.6% | 11.8% |
| Revenue growth a year, past | +39.2%over 5 years | +11.7%over 5 years |
| EPS growth a year, past | – | -3.8%over 5 years |
| Gross margin | – | 88.3% |
|---|---|---|
| Operating margin | 44.8% | 5.3% |
| Net margin | 19.5% | 3.5% |
| ROIC | 84.3% | 11.3% |
| ROE | 119.9% | 15.5% |
| Cash | $185M | $28.5B |
|---|---|---|
| Total debt | – | $74.3B |
| Net debt / EBITDA | – | 1.6 |
| Interest cover | 14.4× | 6.2× |
| Dividend yield | – | 2.6% |
|---|---|---|
| Dividend per share, 12 months | – | $9.06 |
| Dividend growth a year, past | – | +12.6%over 5 years |
| Buyback yield | – | 1.8% |
| Shareholder yield | – | 4.3% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, UnitedHealth ($318B) is about 390.6 times MeiraGTx ($813M), at today's prices.
Since November 17, 2021, MGTX's price moved -58.1% and UNH's -22.1%. With dividends: MGTX -58.1% (-16.0% a year), UNH -14.7% (-3.1% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for MeiraGTx and 2.59% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.
At today's price, the P/E is 10.4 for MGTX and 20.0 for UNH. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 19.5% for MeiraGTx and 3.5% for UnitedHealth, and the operating margin 44.8% and 5.3%. Revenue was $402M and $450B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.